Celldex Therapeutics (CLDX) Other Accumulated Expenses (2010 - 2026)
Celldex Therapeutics (CLDX) posted Other Accumulated Expenses of $1.23 million for Q2 2026, up 32.3% from $930,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Other Accumulated Expenses (2010 - 2026) Analysis & Trends
Since Q4 2010, Celldex Therapeutics has reported Other Accumulated Expenses for 62 quarters.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of -18.3% (FY2020 to FY2025).
- In prior years, Celldex Therapeutics' Other Accumulated Expenses was $942,000 in FY2024 (-76.4%), $3.99 million in FY2023 (+302.8%), $990,000 in FY2022 (-36.3%) and $1.55 million in FY2021 (-53.9%).
- Quarterly Other Accumulated Expenses has run from a low of $930,000 in Q2 2025 to a high of $4.23 million in Q3 2023 over five years.
- On a year-over-year basis, Other Accumulated Expenses increased in two of the last eight quarters, with an average decline of 33.9%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2023, with growth of 302.8%; the weakest was Q4 2024, with a decline of 76.4%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $1.23 million (Q1 2026), $1.23 million (Q4 2025) and $930,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Celldex Therapeutics | 2.48 Bn | 2.48 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 930,000.00 |
| Jun 30, 2025 | 930,000.00 |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 942,000.00 |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 3.67 Mn |
| Mar 31, 2024 | 3.88 Mn |
| Dec 31, 2023 | 3.99 Mn |
| Sep 30, 2023 | 4.23 Mn |
| Jun 30, 2023 | 978,000.00 |
| Mar 31, 2023 | 978,000.00 |
| Dec 31, 2022 | 990,000.00 |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.39 Mn |
| Mar 31, 2022 | 2.51 Mn |
| Dec 31, 2021 | 1.55 Mn |
| Sep 30, 2021 | 1.72 Mn |
API Access
Celldex Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();